PubMed دسترسی آزاد

Determinants and typologies of health system resilience: A data-driven framework for prioritising investment.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

Health system resilience is essential for effective pandemic response and health security, yet existing assessments often lack actionable guidance for policymakers. This study develops a data-driven framework to identify key resilience contributors and country capability profiles using the complete 2021 Global Health Security Index (GHSI) dataset for 195 countries. Through a multi-method analytical approach, we derive a composite resilience measure that captures 70.6% of shared variance across six GHSI domains. After accounting for inter-domain correlations, Detection, Health Capacity, and Prevention show the strongest independent associations with overall resilience (ridge coefficients of 0.242, 0.228, and 0.219, respectively), with Detection contributing most. Cluster analysis reveals two distinct country typologies: a high-performing, balanced-capability group (33% of countries) spanning both high-income and several upper-middle-income countries, and a larger group (67%) with lower and more structurally uneven capabilities, particularly in Prevention and Health Capacity. These profiles suggest different strategic pathways for system strengthening-from sustaining advanced capacities in high-performing countries to targeted investments in detection and core health functions in settings with more fragmented capabilities. Our findings provide an essential framework for comparing resilience across countries and prioritising investments where they matter most, offering practical guidance for national and global health security planning.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2027

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and enviro…

PubMed2026

Global, Regional and National Burden of Viral Hepatitis From 1990 to 2021 With Forecasts to 2046: Findings From the Global Burden of Disease Study 2021.

Viral hepatitis constitutes a primary cause of liver cirrhosis and carcinoma and ranks as the second leading cause of mortality worldwide due to challenges in early detection and limited preventive measures, thereby posing a significant threat to public health. This study analyses the burden and risk factors associated with viral hepatitis at global, regional, and national levels from 1990 to 2021, and projects the disease burden from …

PubMed2026

Temporal trend analysis of the global prevalence of vision impairment and blindness attributable to diabetes from 1990 to 2021.

BACKGROUND: This study aimed to systematically assess the burden and temporal patterns of vision impairment due to diabetes mellitus (DM), including moderate vision loss (MVL), severe vision loss (SVL), and blindness, and to identify the demographic drivers of future changes. METHODS: An age-period-cohort (APC) model was used to evaluate the effects of age, period, and birth cohort on diabetes-related vision impairment, with analyses s…

PubMed2026

Antimicrobial resistance and social inequity: Why the one health approach must centre poverty.

Antimicrobial resistance (AMR) is one of the most consequential threats to global public health. In 2021, bacterial AMR was associated with an estimated 4.71 million deaths globally, including 1.14 million directly attributable to resistance. Yet, despite its designation as a global emergency, policy responses remain heavily focused on surveillance, antimicrobial stewardship, diagnostics, and pharmaceutical innovation. These interventi…